San Diego-based mostly Viking Therapeutics marked alone as a significant competitor within the weight loss drug sector in February after revealing promising info from a mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection and in March the company unv